83 related articles for article (PubMed ID: 17122638)
1. Immunohistochemical expression of Bcl-2, Bcl-x, and Bax in follicular carcinomas of the thyroid.
Haynik DM; Prayson RA
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):417-21. PubMed ID: 17122638
[TBL] [Abstract][Full Text] [Related]
2. Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland.
Branet F; Brousset P; Krajewski S; Schlaifer D; Selves J; Reed JC; Caron P
J Clin Endocrinol Metab; 1996 Jul; 81(7):2726-30. PubMed ID: 8675602
[TBL] [Abstract][Full Text] [Related]
3. bcl2, p53 and bax in thyroid tumors and their relation to apoptosis.
Farid P; Gomb SZ; Péter I; Szende B
Neoplasma; 2001; 48(4):299-301. PubMed ID: 11712682
[TBL] [Abstract][Full Text] [Related]
4. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
[TBL] [Abstract][Full Text] [Related]
5. Determination-of apoptosis and cell cycle modulators (p16, p21, p27, p53, BCL-2, Bax, BCL-xL, and cyclin D1) in thyroid follicular carcinoma, follicular adenoma, and adenomatous nodules via a tissue microarray method.
Temiz P; Akkaş G; Neşe N; Uğur Duman F; Karakaş C; Erhan Y
Turk J Med Sci; 2015; 45(4):865-71. PubMed ID: 26422859
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of intracellular proapoptotic (Bax, Bak) and antiapoptotic (Bcl-2, Bcl-XL) proteins expression in thyrocytes from young patients with immune and non-immune thyroid disorders].
Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J
Pediatr Endocrinol Diabetes Metab; 2007; 13(2):63-70. PubMed ID: 17880809
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of Bcl-2, Bax, and Bak expression in thyroid glands from patients with subacute thyroiditis.
Koga M; Hiromatsu Y; Jimi A; Toda S; Koike N; Nonaka K
J Clin Endocrinol Metab; 1999 Jun; 84(6):2221-5. PubMed ID: 10372734
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of cyclooxygenase 2 in follicular carcinomas of the thyroid.
Haynik DM; Prayson RA
Arch Pathol Lab Med; 2005 Jun; 129(6):736-41. PubMed ID: 15913419
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2, bcl-x, and bax expression in dysembryoplastic neuroepithelial tumors.
Prayson RA
Clin Neuropathol; 2000; 19(2):57-62. PubMed ID: 10749285
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological correlations of Bcl-xL and Bax expression in differentiated thyroid carcinoma.
Martínez-Brocca MA; Castilla C; Navarro E; Amaya MJ; Travado P; Japón MA; Sáez C
Clin Endocrinol (Oxf); 2008 Feb; 68(2):190-7. PubMed ID: 17803695
[TBL] [Abstract][Full Text] [Related]
11. Image cytometric bcl-2:bax and bcl-2:bcl-x ratios in invasive breast carcinoma: correlation with prognosis.
Schiller AB; Clark WS; Cotsonis G; Lawson D; DeRose PB; Cohen C
Cytometry; 2002 Aug; 50(4):203-9. PubMed ID: 12210599
[TBL] [Abstract][Full Text] [Related]
12. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
[TBL] [Abstract][Full Text] [Related]
13. Expression of apoptosis-related proteins in thyroid tumors and thyroid carcinoma cell lines.
Bröcker M; de Buhr I; Papageorgiou G; Schatz H; Derwahl M
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():20-3. PubMed ID: 8980994
[TBL] [Abstract][Full Text] [Related]
14. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma.
Logsdon MD; Meyn RE; Besa PC; Pugh WC; Stephens LC; Peters LJ; Milas L; Cox JD; Cabanillas F; Brisbay S; Andersen M; McDonnell TJ
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):19-29. PubMed ID: 10219790
[TBL] [Abstract][Full Text] [Related]
16. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
17. [Expression of protooncogene bcl-2 in thyroid tumors].
Zhu J; Chen Y; Xue H
Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):829-31. PubMed ID: 9275533
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.
Magistrelli P; Coppola R; Tonini G; Vincenzi B; Santini D; Borzomati D; Vecchio F; Valeri S; Castri F; Antinori A; Nuzzo G; Caraglia M; Picciocchi A
J Cell Biochem; 2006 Jan; 97(1):98-108. PubMed ID: 16173075
[TBL] [Abstract][Full Text] [Related]
19. Bag-1 expression in thyroid neoplasm: its correlation with Bcl-2 expression and carcinoma dedifferentiation.
Ito Y; Yoshida H; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A
Anticancer Res; 2003; 23(1B):569-76. PubMed ID: 12680148
[TBL] [Abstract][Full Text] [Related]
20. HLA-G is differentially expressed in thyroid tissues.
de Figueiredo Feitosa NL; Crispim JC; Zanetti BR; Magalhães PK; Soares CP; Soares EG; Neder L; Donadi EA; Maciel LM
Thyroid; 2014 Mar; 24(3):585-92. PubMed ID: 24089994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
